Jean Coutu Group (TSE:PJC.A) Rating Restated
Investment analysts at Scotia Capital have $19.00 price target on Jean Coutu Group (TSE:PJC.A). Scotia Capital’s price target would suggest a potential downside of -8.61 % from the company’s current stock price. The rating was disclosed to clients in a note on Friday morning.
According to data compiled by Thomson Reuters, Jean Coutu Group (TSE:PJC.A)’s stock is covered by 10 equity analysts across the Street, with 4 analysts giving it a Sell rating, 1 a Buy rating, while 6 consider it a Hold. The 12-month consensus target price for the stock is $14.4, which reflects an downside potential of 30.90% over the current price.
Jean Coutu Group (TSE:PJC.A) Profile
The Jean Coutu Group (PJC) Inc. is a Canada-based company, which is engaged in franchising pharmacy chains. The Company operates through two segments: franchising and generic drugs. Within the franchising segment, the Company carries on the franchising activity under the banners of PJC Jean Coutu, PJC Clinique, PJC Jean Coutu Sante and PJC Jean Coutu Sante Beaute; operates approximately two distribution centers, and coordinates various other services for its franchisees.
Jean Coutu Group (TSE:PJC.A) traded up 0.92% on 23 December, hitting $20.84. A total of 35,548 shares of the company’s stock traded hands. This is down from average of 176,013 shares. Jean Coutu Group has a 52 week low of $17.02 and a 52 week high of $22.41. The company has a market cap of $3.83B and a P/E ratio of 18.46.
Get the latest Jean Coutu Group (TSE:PJC.A) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.
The post Scotia Capital Analyst Reaffirmed $19.00 Price Target on Jean Coutu Group (TSE:PJC.A) stock, While Reiterating Sector Perform Rating appeared first on Octafinance.